Skip to main content
Boule Diagnostics logo

Boule Diagnostics — Investor Relations & Filings

Ticker · BOUL ISIN · SE0011231158 LEI · 213800IK1TGY858TKZ45 ST Manufacturing
Open in API
Filings indexed 223 across all filing types
Latest filing 2014-11-05 Interim / Quarterly Rep…
Country SE Sweden
Listing ST BOUL

About Boule Diagnostics

https://boule.com/

Boule Diagnostics is a global provider of diagnostic solutions specializing in hematology. The company develops, manufactures, and markets systems and consumables for blood diagnostics, including hematology analyzers, clinical chemistry analyzers, and associated reagents, controls, and calibrators. Its products are tailored for decentralized healthcare settings in both the human and veterinary markets, such as smaller laboratories and clinics. The company aims to enhance global healthcare access by providing high-quality instruments that deliver timely and accurate blood test results.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2014
Interim / Quarterly Report Classification · 1% confidence The document is a 'Delårsrapport' (Interim Report) for Boule Diagnostics AB for the period January–September 2014. It contains comprehensive financial statements, including income statements, balance sheets, cash flow analysis, and management commentary on business performance, regional sales, and risk factors. It is not an announcement of a report, but the report itself, and it contains substantive financial data, fitting the definition of an Interim/Quarterly Report. 9M 2014
2014-11-05 Swedish
Major Shareholding Notification 2014
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding for 'Linc Invest AB' in 'Boule Diagnostic AB'. It explicitly mentions 'Reason for major shareholding notification Buy' and provides the 'Before the transaction' and 'After the transaction' share quantities, resulting in a new percentage of 10% of voting rights. This structure perfectly matches the definition of a Major Shareholding Notification, which corresponds to the filing code MRQ.
2014-09-05 English
Interim / Quarterly Report 2014
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive interim financial report for the period January–June 2014, titled 'Delårsperioden januari–juni 2014'. It contains detailed financial statements, management commentary, balance sheets, cash flow analysis, and notes on accounting principles. It is not a mere announcement or certification, but the full interim report itself. H1 2014
2014-08-28 Swedish
Major Shareholding Notification 2014
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding percentage for a specific holder ('Linc ab') in 'Boule Diagnostic AB'. It explicitly states the 'Reason for major shareholding notification' and provides 'Before' and 'After' transaction details, including the resulting percentage of voting rights (10%). This content directly corresponds to the definition of a Major Shareholding Notification.
2014-05-27 English
Kommuniké från Boule Diagnostics ABs årsstämma den 13 maj 2014
AGM Information Classification · 1% confidence The document is titled 'Kommuniké från Boule Diagnostics ABs årsstämma den 13 maj 2014' (Communiqué from Boule Diagnostics AB's Annual General Meeting on May 13, 2014). It details decisions made regarding the approval of financial statements, dividend declaration, board member elections, remuneration, and approval of stock option programs, all of which are typical outcomes of an Annual General Meeting (AGM). Although it is a summary communiqué, the core subject matter is the results and decisions of the AGM. Therefore, it fits the AGM Information category (AGM-R). The document length is short (3530 chars), but it is a summary of decisions, not just an announcement that a report is available, making AGM-R more specific than RPA or RNS.
2014-05-14 Swedish
Interim / Quarterly Report 2014
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive quarterly financial report for Boule Diagnostics AB for the period January-March 2014. It contains detailed financial statements (income statement, balance sheet, cash flow), management commentary, key performance indicators, and notes on accounting principles. It is not an announcement of a report (RPA) because it contains the full substantive financial data, nor is it a certification. It fits the definition of an Interim/Quarterly Report (IR). Q1 2014
2014-05-13 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.